17
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36293 |
PAR 4 (1-6)
|
||
PAR 4 (1-6) 可用于生命科学领域的相关研究。其产品编号为 T36293,CAS号为 225779-44-2。 | |||
TP1065 |
PAR-4 Agonist Peptide, amide TFA
PAR-4-AP (TFA),AY-NH2 (TFA) |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) 是一种蛋白酶激活受体 4 (PAR-4) 激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T23189 |
prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens]
|
Others | Others |
Prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] is a peptide with the sequence H2N-Ala-Thr-Gly-Gly-Tyr-Arg-OH, MW= 623.66. | |||
T7623L |
PAR-4 Agonist Peptide, amide acetate
PAR-4 Agonist Peptide, amide acetate(352017-71-1 free base) |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide acetate 是蛋白酶激活受体 4 (PAR-4) 的激动剂。 | |||
T7623 |
PAR-4 Agonist Peptide, amide
AY-NH2,PAR-4 Agonist Peptide, amide(2TFA),PAR-4-AP |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide (AY-NH2) 是蛋白酶激活受体 4 (PAR-4) 的激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T7740 |
Protease-Activated Receptor-4 diTFA
Protease-Activated Receptor-4 diTFA(245443-52-1(free base)) |
Protease-activated Receptor | GPCR/G Protein |
Protease-Activated Receptor-4 diTFA 是蛋白酶激活受体 4 (PAR4) 激动剂。 | |||
TP1925L |
tcY-NH2 TFA(327177-34-4 free base)
|
Protease-activated Receptor | GPCR/G Protein |
tcY-NH2 TFA(327177-34-4 free base) 是一种选择性 PAR4 拮抗肽。抑制凝血酶诱导的内皮抑素释放和血小板聚集。 | |||
T63966 |
BMS-986141
UDM-003183 |
Protease-activated Receptor | GPCR/G Protein |
BMS-986141(UDM-003183) 是一种具有口服活性的选择性和高效性的凝血酶受体蛋白酶激活受体-4 (protease-activated receptor-4 (PAR-4)) 拮抗剂,其 IC50 值为 0.4 nM。BMS-98614 表现出显著的抗血栓作用。 | |||
T14684 |
BMS-986120
|
Others | Others |
BMS-986120 is a first-in-class oral and reversible protease-activated receptor 4 (PAR4) antagonist. With IC50s of 9.5 nM and 2.1 nM in human and monkey blood, respectively. BMS-986120 has potent and selective antiplatelet effects[1][2]. | |||
T7380 |
Protease-Activated Receptor-4
蛋白酶活化的受体-4 |
Protease-activated Receptor | GPCR/G Protein |
Protease-Activated Receptor-4 是蛋白酶激活受体 4 激动剂,具有抗血小板治疗。 | |||
T21901 |
ML-354
|
||
ML354 是一种选择性 PAR4拮抗剂,其 IC50为 140 nM。 | |||
T29140 |
VU0652925
VU 0652925,BMS-3,VU-0652925,BMS3,BMS 3 |
||
VU0652925 is a PAR4 antagonist. VU0652925 has a P-sel IC50 of 39.2 pM (-pIC50±SEM: 10.41±0.04) and a PAC1 IC50 of 43.0 pM (-pIC50±SEM: 10.4±0.04). | |||
TP1925 |
tcY-NH2
|
||
Selective PAR4 antagonist peptide. Inhibits endostatin release and platelet aggregation induced by thrombin. | |||
T75874 |
tcY-NH2 TFA
|
||
tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) TFA 是一种有效的 PAR4选择性肽类拮抗剂。tcY-NH2 TFA 抑制凝血酶和 AY-NH2诱导的血小板聚集和内皮抑素释放,可用于炎症、免疫学的研究。 | |||
T75904 |
PAR 4 (1-6) (TFA)
|
||
GYPGQV TFA (PAR 4 (1-6) TFA) 是一种六肽,作为蛋白酶激活受体 4 (PAR4) 片段,能特异性抑制PAR4。 | |||
T80502 |
P4pal10
|
||
P4pal10为PAR4拮抗剂,能在体内抑制凝血酶介导的小鼠血小板聚集,并显著减少Carrageenan引起的水肿及粒细胞浸润。 | |||
T17200 |
UDM-001651
|
Others | Others |
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN6872 |
Trypsin
|
Protease-activated Receptor | GPCR/G Protein |
Trypsin 是一种可从鱼类分离出的丝氨酸蛋白酶,可水解赖氨酸或精氨酸羧基侧蛋白质。Trypsin 具有抗炎活性,可通过 PDCoV 的 S 糖蛋白与 pAPN 的相互作用诱导 PDCoV 感染的细胞膜融合,可激活 PAR2 和 PAR4,促进细胞增殖和分化。Trypsin 可用于促进伤口愈合和研究神经源性炎症。 |